FIORENZATO, ELEONORA
 Distribuzione geografica
Continente #
NA - Nord America 1.357
EU - Europa 581
AS - Asia 189
AF - Africa 7
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.139
Nazione #
US - Stati Uniti d'America 1.347
IT - Italia 429
CN - Cina 86
SG - Singapore 79
SE - Svezia 29
DE - Germania 27
FR - Francia 24
FI - Finlandia 18
IN - India 14
NL - Olanda 13
CH - Svizzera 9
GB - Regno Unito 7
RU - Federazione Russa 6
CA - Canada 4
EG - Egitto 4
MX - Messico 4
UA - Ucraina 4
ES - Italia 3
GR - Grecia 3
ID - Indonesia 3
IE - Irlanda 3
CL - Cile 2
CU - Cuba 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
HK - Hong Kong 2
KR - Corea 2
NO - Norvegia 2
AU - Australia 1
BE - Belgio 1
BG - Bulgaria 1
BR - Brasile 1
EU - Europa 1
IR - Iran 1
JP - Giappone 1
PH - Filippine 1
ZA - Sudafrica 1
Totale 2.139
Città #
Fairfield 217
Ashburn 151
Chandler 102
Woodbridge 99
Cambridge 93
Seattle 86
Houston 75
Padova 69
Wilmington 69
Singapore 64
Milan 63
Rome 46
Beijing 41
Ann Arbor 31
San Diego 31
Princeton 30
Medford 29
Des Moines 26
Santa Clara 21
Roxbury 18
Helsinki 16
Naples 11
Pune 9
Guangzhou 8
Verona 8
Geneva 7
Nanjing 7
Boardman 6
Cagliari 6
Los Angeles 6
Rovigo 6
Turin 6
Bergamo 5
Chita 5
Frankfurt am Main 5
Vicenza 5
Cairo 4
Rho 4
Shenyang 4
Venice 4
Vigonza 4
Apodaca 3
Athens 3
Barcellona Pozzo di Gotto 3
Bologna 3
Brendola 3
Chions 3
Council Bluffs 3
Dublin 3
Freiburg im Breisgau 3
Kharkiv 3
Monza 3
Nanchang 3
Ogden 3
Sassari 3
Wittnau 3
Amsterdam 2
Apex 2
Bari 2
Bitetto 2
Borgosesia 2
Budrio 2
Calalzo di Cadore 2
Cassino 2
Cernusco sul Naviglio 2
Changsha 2
Chiavari 2
Conselve 2
Dallas 2
Davangere 2
Dongguan 2
Fasano 2
Ferrara 2
Fislisbach 2
Genoa 2
Groningen 2
Hanover 2
Havana 2
Heeze 2
Jakarta 2
Jiaxing 2
Las Vegas 2
Lecce 2
Limena 2
London 2
Macerata 2
Madrid 2
Matera 2
Oslo 2
Parkton 2
Parma 2
Pavia 2
Pescara 2
Pietrasanta 2
Pioltello 2
Québec 2
San Donato di Lecce 2
Santiago 2
Southwark 2
Stillwater 2
Totale 1.630
Nome #
Cognitive and Brain Imaging Changes in Parkinsonism 271
Brain structural profile of multiple system atrophy patients with cognitive impairment 106
Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease 97
Brain Amyloid Contribution to Cognitive Dysfunction in Early-Stage Parkinson's Disease: The PPMI Dataset 95
Dynamic functional connectivity changes associated with dementia in Parkinson's disease 87
Anatomical profile of cognitive impairment in MSA 77
Double-blind randomized trial of t-DCS versus sham in Parkinson patients with mild cognitive impairment receiving cognitive training 76
Automated MRI Classification in Progressive Supranuclear Palsy: A Large International Cohort Study 76
Nonmotor Symptoms and Natural History of Parkinson's Disease: Evidence From Cognitive Dysfunction and Role of Noninvasive Interventions 76
Impact of Cognitive Profile on Impulse Control Disorders Presence and Severity in Parkinson's Disease 73
Do Old Errors Always Lead to New Truths? A Randomized Controlled Trial of Errorless Goal Management Training in Brain-Injured Patients 71
Cognitive impairment in multiple system atrophy 70
The interplay between asymmetric dopaminergic degeneration, brain structural changes and cognition in de-novo PD: The PPMI dataset 68
A New MRI Measure to Early Differentiate Progressive Supranuclear Palsy From De Novo Parkinson's Disease in Clinical Practice: An International Study 65
Differences in cognitive profiles between Lewy body and Parkinson’s disease dementia 63
Cognitive Rehabilitation in Parkinson's Disease: Is it Feasible? 62
Cognitive and mental health changes and their vulnerability factors related to COVID-19 lockdown in Italy 61
Reply: Dynamic functional connectivity changes in Lewy body disease 60
Asymmetric Dopamine Transporter Loss Affects Cognitive and Motor Progression in Parkinson's Disease 60
The contribution of beta-amyloid to dementia in Lewy body diseases: a 1-year follow-up study 56
MoCA vs. MMSE sensitivity as screening instruments of cognitive impairment in PD, MSA and PSP patients 49
Cognitive profiling in patients with Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy: a 15-month longitudinal study 47
Validation of the Italian version of the Parkinson's Disease- Cognitive Functional Rating Scale 43
Safety and efficacy of cognitive rehabilitation in PD with cognitive impairments 43
null 40
Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy 34
Brain structural abnormalities in multiple system atrophy patients with cognitive impairment 33
Multimodal PET/MRI Study of Connectivity in Cognitively Impaired Patients with Parkinson’s Disease 28
Clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes 25
Profile and progression of cognitive deficits in Progressive Supranuclear Palsy, Multiple System Atrophy and Parkinson's Disease 23
Performance at the Category-Exemplars language test (CATEX) in Parkinson's disease and Huntington's disease Italian population 23
Brain connectivity changes associated with t‐DCS and cognitive training plus cognitive training in Parkinson's disease with mild cognitive impairment 22
The effectiveness of an immersive virtual reality and telemedicine-based cognitive intervention on prospective memory in Parkinson’s disease patients with mild cognitive impairment and healthy aged individuals: design and preliminary baseline results of a placebo-controlled study 22
Quantification of Brain β-Amyloid Load in Parkinson's Disease With Mild Cognitive Impairment: A PET/MRI Study 20
Biomarkers of aging in frailty and age-associated disorders: State of the art and future perspective 18
Development and Validation of Automated Magnetic Resonance Parkinsonism Index 2.0 to Distinguish Progressive Supranuclear Palsy-Parkinsonism From Parkinson's Disease 12
Brain Dynamics Complexity as a Signature of Cognitive Decline in Parkinson's Disease 10
Gender differences in the effects of emotion induction on intertemporal decision-making 9
The pharmacological management of the behavioral aspects of Parkinson’s disease: an update 8
Attitudes Toward the Adoption of Remote Patient Monitoring and Artificial Intelligence in Parkinson’s Disease Management: Perspectives of Patients and Neurologists 8
Erratum: Double-blind Randomized Trial of tDCS Versus Sham in Parkinson Patients with Mild Cognitive Impairment Receiving Cognitive Training (Brain Stimulation (2015) 8 (1223-1225) DOI: 10.1016/j.brs.2015.07.043) 8
One-year into COVID-19 pandemic: Decision-making and mental-health outcomes and their risk factors 6
null 4
Totale 2.205
Categoria #
all - tutte 10.165
article - articoli 7.047
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 312
Totale 17.524


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020218 0 0 0 17 31 18 22 33 43 21 30 3
2020/2021292 11 6 7 12 8 57 18 22 44 34 44 29
2021/2022441 26 38 32 14 13 92 25 17 21 51 28 84
2022/2023396 58 8 15 20 60 53 4 46 72 10 33 17
2023/2024523 32 45 40 40 44 58 65 49 28 16 54 52
2024/2025201 40 112 49 0 0 0 0 0 0 0 0 0
Totale 2.205